LSTM Home > LSTM Research > LSTM Online Archive

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection.

Downloads

Downloads per month over past year

O'Shea, Matthew K, Tanner, Rachel, Müller, Julius, Harris, Stephanie A, Wright, Danny, Stockdale, Lisa, Stylianou, Elena, Satti, Iman, Smith, Steven G, Dunbar, James, Fletcher, Tom E., Dedicoat, Martin, Cunningham, Adam F and McShane, Helen (2018) 'Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection.'. Scientific Reports, Vol 8, Issue 1, p. 14480.

[img]
Preview
Text
sci report_immunological correlates of mycobaterial_published.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

A major contribution to the burden of Tuberculosis (TB) comes from latent Mycobacterium tuberculosis infections (LTBI) becoming clinically active. TB and LTBI probably exist as a spectrum and currently there are no correlates available to identify individuals with LTBI most at risk of developing active disease. We set out to identify immune parameters associated with ex vivo mycobacterial growth control among individuals with active TB disease or LTBI to define the spectrum of TB infection. We used a whole blood mycobacterial growth inhibition assay to generate a functional profile of growth control among individuals with TB, LTBI or uninfected controls. We subsequently used a multi-platform approach to identify an immune signature associated with this profile. We show, for the first time, that patients with active disease had the greatest control of mycobacterial growth, whilst there was a continuum of responses among latently infected patients, likely related to the degree of immune activation in response to bacillary load. Control correlated with multiple factors including inflammatory monocytes, activated and atypical memory B cells, IgG1 responses to TB-specific antigens and serum cytokines/chemokines. Our findings offer a method to stratify subclinical TB infections and the future potential to identify individuals most at risk of progressing to active disease and benefit from chemoprophylaxis.

Item Type: Article
Subjects: WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General)
WF Respiratory System > Tuberculosis > WF 250 Immunological aspects
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI): https://doi.org/10.1038/s41598-018-32755-x
Depositing User: Stacy Murtagh
Date Deposited: 02 Oct 2018 14:20
Last Modified: 12 Oct 2018 09:30
URI: http://archive.lstmed.ac.uk/id/eprint/9409

Statistics

View details

Actions (login required)

Edit Item Edit Item